Can We Predict Bevacizumab Responders in Patients With Glioblastoma?

MeSH terms

• Angiogenesis Inhibitors / therapeutic use*
• Antineoplastic Agents, Alkylating / therapeutic use*
• Bevacizumab / therapeutic use*
• Brain Neoplasms / drug therapy*
• Brain Neoplasms / mortality*
• Dacarbazine / analogs & derivatives*
• Female
• Glioblastoma / drug therapy*
• Glioblastoma / mortality*
• Humans
• Male